Erratum: Applications of pHLIP Technology for Cancer Imaging and Therapy (Trends in Biotechnology (2017) 35(7) (653–664), (S016777991730063X) (10.1016/j.tibtech.2017.03.014))
Document Type
Article
Date of Original Version
12-1-2018
Abstract
The following declaration of interests was inadvertently omitted from the published article: Disclaimer Statement Oleg A. Andreev, Donald M. Engelman, Jason S. Lewis, and Yana K. Reshetnyak are co-founders of a company, pHLIP, Inc., and are, respectively, the Chairman (O.A.A.), head of the Scientific Advisory Board (D.M.E.), and President and CEO (Y.K.R.). We are not paid, but have financial interests in the company as shareholders. The statement has been added to the article online. The authors regret the error.
Publication Title, e.g., Journal
Trends in Biotechnology
Volume
36
Issue
12
Citation/Publisher Attribution
Wyatt, Linden C., Jason S. Lewis, Oleg A. Andreev, Yana K. Reshetnyak, and Donald M. Engelman. "Erratum: Applications of pHLIP Technology for Cancer Imaging and Therapy (Trends in Biotechnology (2017) 35(7) (653–664), (S016777991730063X) (10.1016/j.tibtech.2017.03.014))." Trends in Biotechnology 36, 12 (2018): 1300. doi: 10.1016/j.tibtech.2017.11.005.